Term
| Used to minimize skin dryness, applied multiple times/day, applied after bathing |
|
Definition
|
|
Term
| Bathing in waters containing certain salts (Dead Sea, Kangal Hot Spring, Blue Lagoon) |
|
Definition
|
|
Term
| Removes scales to smooth skin, decreases hyperkeratosis |
|
Definition
|
|
Term
| Synthetic retinoid and prodrug available topically once a day |
|
Definition
|
|
Term
| Most commonly used; used to decrease erythema, scaling, and pruritus |
|
Definition
|
|
Term
| 2nd line therapy (lack of efficacy compared to other topical therapies), used for long time for psoriasis treatment |
|
Definition
|
|
Term
| 2nd line topical therapy; treats chronic plaque-type and guttate psoriasis |
|
Definition
|
|
Term
| Cellular and systemic calcium metabolism; oral agent use limited to hypercalcemia associated with its use |
|
Definition
| Vitamin D analogues (Calcipotriene, Calcitriol, Tacalcitol) |
|
|
Term
| Treatment of severe psoriasis (ethrodermic, pustular types, and plaque type) and useful as adjunctive |
|
Definition
| Acitretin (oral Retinoid) |
|
|
Term
| Used for both cutaneous and arthritic forms (severe psoriasis) |
|
Definition
|
|
Term
| Used only for severe psoriasis |
|
Definition
|
|
Term
| Antimetabolite, good for psoriatic arthritis |
|
Definition
|
|
Term
| Used more commonly for IBD and RA, can be used for psoriatic arthritis, takes longer to take effect |
|
Definition
|
|
Term
| Antimetabolite, less effective than methotrexate but used in patients with liver dysfunction |
|
Definition
|
|
Term
| Efficacy enhanced with emollients; Combination with Anthralin, Calcipotriene, Topical retinoid, Systemic therapy (oral retinoid, methotrexate) |
|
Definition
|
|
Term
| FDA indications: psoriatic arthritis and severe plaque psoriasis; Dosed 3 times at weeks 0. 2. and 6 |
|
Definition
|
|
Term
| FDA indications: psoriatic arthritis and plaque psoriasis; dosed twice weekly SC |
|
Definition
|
|
Term
| FDA indication: psoriatic arthritis and plaque psoriasis;dosed weekly or every 2 weeks SC |
|
Definition
|
|
Term
| FDA indication: plaque psoriasis and arthritis form; IM injection weekly |
|
Definition
|
|
Term
| Decrease progressive joint damage |
|
Definition
| Entercept, adalimumab, and infliximab |
|
|
